The first case of methemoglobinemia associated with omalizumab

J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1414-1415. doi: 10.1016/j.jaip.2017.11.037. Epub 2018 Jan 12.

Authors

Caroline Kronborg¹, Marsus Pumar², Andrew Gillman²

Affiliations

¹ Department of Allergy, Asthma, and Clinical Immunology, Alfred Health, Melbourne, Australia. Electronic address: caroline.kronborg@gmail.com.
² Department of Allergy, Asthma, and Clinical Immunology, Alfred Health, Melbourne, Australia.

PMID: 29339124
DOI: 10.1016/j.jaip.2017.11.037

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Allergens / immunology
Chronic Disease
Drug Hypersensitivity / diagnosis*
Female
Humans
Immunoglobulin E / immunology
Methemoglobinemia / diagnosis*
Middle Aged
Omalizumab / adverse effects*
Omalizumab / immunology
Omalizumab / therapeutic use
Urticaria / drug therapy*

Substances

Allergens
Omalizumab
Immunoglobulin E